Discovery of tanshinone derivatives with anti-MRSA activity via targeted bio-transformation

Synth Syst Biotechnol. 2016 Jul 1;1(3):187-194. doi: 10.1016/j.synbio.2016.05.002. eCollection 2016 Sep.

Abstract

Two potent anti-MRSA tanshinone glycosides (1 and 2) were discovered by targeted microbial biotransformation, along with rapid identification via MS/MS networking. Serial reactions including dehydrogenation, demethylations, reduction, glycosylation and methylation have been observed after incubation of tanshinone IIA and fungus Mucor rouxianus AS 3.3447. In addition, tanshinosides B (2) showed potent activities against serial clinical isolates of oxacillin-resistant Staphylococcus aureus with MIC values of 0.78 μg/mL. This is the first study that shows a significant increase in the level and activities of tanshinone glycosides relative to the substrate tanshinone IIA.

Keywords: Biotransformation; Glycosylation; Mucor rouxianus; Tanshinone IIA.